AP	action potential
ATP	adenosine triphosphate
BTP2	3,5-bis(trifluoromethyl)pyrazole derivative
CBA	4-chloro-2-[[2-(2-chlorophenoxy)acetyl]amino]benzoic acid
CFTR	cystic fibrosis transmembrane conductance regulator
CHO	Chinese hamster ovary
DCDPC	3′,5-dichlorodiphenylamine-2-carboxylic acid
DPC	diphenylamine-2-carboxylic acid
DV	decavanadate
EC50	half effective activator concentration
FFA	flufenamic acid
HEK	human embryonic kidney
HUVEC	human umbilical vein endothelial cells
IC50	half inhibitory concentration
IP3	inositol 1,4,5-trisphosphate
I(NSCCa)	Ca2+-activated nonspecific cationic current
KATP	adenosine triphosphate-dependent K+
KCax.x	Ca2+-activated K+ channels type x.x
Kirx.x	inward rectifier K+ channel type x.x
KD	knock-down
KO	knock-out
LBA	4-chloro-2-(2-(4-chloro-2-methylphenoxy)propanamido) benzoic acid
LNCaP	lymph node carcinoma of the prostate
NBA	4-chloro-2-(1-naphthyloxyacetamido)benzoic acid
NMDA	N-methyl-d-aspartic acid
NO	nitric oxide
NPPB	5-nitro-2-(3-phenylpropylamino)benzoic acid
NSCCa	Ca2+-activated nonspecific cationic channel
PIP2	phosphatidylinositol 4,5-bisphosphate
PKC	protein kinase C
PLC	phospholipase C
PMA	phorbol 12-myristate 13-acetate
tPA	tissue plasminogen activator
siRNA	small interfering RNA
SUR1	sulfonylurea receptor 1
TRP	transient receptor potential
TRPA	transient receptor potential ankyrin
TRPC	transient receptor potential canonical
TRPM	transient receptor potential melastatin
TRPML	transient receptor potential mucolipin
TRPP	transient receptor potential polycystin
TRPV	transient receptor potential vanilloid